image stringlengths 20 66 | question stringclasses 16
values | answer stringlengths 3 10.7k |
|---|---|---|
PMC9427115_fig2s1_389222.jpg | What stands out most in this visual? | The identification of the 220 bp enhancer by promoter bashing.(A-A”’’) UAS-GFP driven by GMR35H02-Gal4 is initiated at the same time as endogenous Slp1 and Slp2 in neuroblasts marked by Dpn. (B-D’’) Expression of GFP reporters driven by SlpL1.5 (B-B’’) and its sub-segments Slpf1-220bp(C-C’’), Slpf2-592bp (D-D’’), and S... |
PMC9427115_fig2s1_389237.jpg | What does this image primarily show? | The identification of the 220 bp enhancer by promoter bashing.(A-A”’’) UAS-GFP driven by GMR35H02-Gal4 is initiated at the same time as endogenous Slp1 and Slp2 in neuroblasts marked by Dpn. (B-D’’) Expression of GFP reporters driven by SlpL1.5 (B-B’’) and its sub-segments Slpf1-220bp(C-C’’), Slpf2-592bp (D-D’’), and S... |
PMC9427115_fig2s1_389235.jpg | What's the most prominent thing you notice in this picture? | The identification of the 220 bp enhancer by promoter bashing.(A-A”’’) UAS-GFP driven by GMR35H02-Gal4 is initiated at the same time as endogenous Slp1 and Slp2 in neuroblasts marked by Dpn. (B-D’’) Expression of GFP reporters driven by SlpL1.5 (B-B’’) and its sub-segments Slpf1-220bp(C-C’’), Slpf2-592bp (D-D’’), and S... |
PMC9427115_fig2s1_389223.jpg | What object or scene is depicted here? | The identification of the 220 bp enhancer by promoter bashing.(A-A”’’) UAS-GFP driven by GMR35H02-Gal4 is initiated at the same time as endogenous Slp1 and Slp2 in neuroblasts marked by Dpn. (B-D’’) Expression of GFP reporters driven by SlpL1.5 (B-B’’) and its sub-segments Slpf1-220bp(C-C’’), Slpf2-592bp (D-D’’), and S... |
PMC9427115_fig7_389258.jpg | What is the dominant medical problem in this image? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389270.jpg | What object or scene is depicted here? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389275.jpg | What is the core subject represented in this visual? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389271.jpg | What is the core subject represented in this visual? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389264.jpg | What is the core subject represented in this visual? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389269.jpg | What is the core subject represented in this visual? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389265.jpg | What is the principal component of this image? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389263.jpg | What stands out most in this visual? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389261.jpg | What is the focal point of this photograph? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389268.jpg | What is being portrayed in this visual content? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389273.jpg | What's the most prominent thing you notice in this picture? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389260.jpg | Can you identify the primary element in this image? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389256.jpg | What can you see in this picture? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389259.jpg | What key item or scene is captured in this photo? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389266.jpg | What key item or scene is captured in this photo? | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig7_389274.jpg | Describe the main subject of this image. | Mutations of predicted binding sites for transcription factors Ey, Su(H) and Scro in the u8772 220 bp enhancer establish their requirement for activating slp1/slp2 mRNA transcription in medulla neuroblasts.Expression of GFP reporter driven by the wild-type 220 bp enhancer (A-A’’’) was compared against GFP reporters dri... |
PMC9427115_fig8_389242.jpg | What is the central feature of this picture? | Mutations of putative binding sites for Ey and Scro in the d5778 850 bp enhancer show their requirement for activating Slp1/Slp2 gene expressions in medulla neuroblasts.A parallel comparison was made for GFP reporter expression driven by the wild-type 850 bp enhancer (A-A’’’) to the GFP reporter expression driven by ve... |
PMC9427115_fig8_389243.jpg | What is the dominant medical problem in this image? | Mutations of putative binding sites for Ey and Scro in the d5778 850 bp enhancer show their requirement for activating Slp1/Slp2 gene expressions in medulla neuroblasts.A parallel comparison was made for GFP reporter expression driven by the wild-type 850 bp enhancer (A-A’’’) to the GFP reporter expression driven by ve... |
PMC9427115_fig8_389239.jpg | What is the main focus of this visual representation? | Mutations of putative binding sites for Ey and Scro in the d5778 850 bp enhancer show their requirement for activating Slp1/Slp2 gene expressions in medulla neuroblasts.A parallel comparison was made for GFP reporter expression driven by the wild-type 850 bp enhancer (A-A’’’) to the GFP reporter expression driven by ve... |
PMC9427115_fig8_389238.jpg | What is shown in this image? | Mutations of putative binding sites for Ey and Scro in the d5778 850 bp enhancer show their requirement for activating Slp1/Slp2 gene expressions in medulla neuroblasts.A parallel comparison was made for GFP reporter expression driven by the wild-type 850 bp enhancer (A-A’’’) to the GFP reporter expression driven by ve... |
PMC9427115_fig9_389254.jpg | What's the most prominent thing you notice in this picture? | Mutation of potential Su(H) binding sites in the d5778 850 bp enhancer does not decrease GFP reporter expression in neuroblasts.To measure GFP intensities in medulla neuroblasts unimpeded by GFP fluorescence from glial cells, UAS-GFP-RNAi; d5778 850 bp >GFP wild type reporter or UAS-GFP-RNAi; d5778 850 Su(H) binding si... |
PMC9427115_fig9_389255.jpg | What is the focal point of this photograph? | Mutation of potential Su(H) binding sites in the d5778 850 bp enhancer does not decrease GFP reporter expression in neuroblasts.To measure GFP intensities in medulla neuroblasts unimpeded by GFP fluorescence from glial cells, UAS-GFP-RNAi; d5778 850 bp >GFP wild type reporter or UAS-GFP-RNAi; d5778 850 Su(H) binding si... |
PMC9427115_fig9_389249.jpg | Describe the main subject of this image. | Mutation of potential Su(H) binding sites in the d5778 850 bp enhancer does not decrease GFP reporter expression in neuroblasts.To measure GFP intensities in medulla neuroblasts unimpeded by GFP fluorescence from glial cells, UAS-GFP-RNAi; d5778 850 bp >GFP wild type reporter or UAS-GFP-RNAi; d5778 850 Su(H) binding si... |
PMC9427115_fig9_389247.jpg | Describe the main subject of this image. | Mutation of potential Su(H) binding sites in the d5778 850 bp enhancer does not decrease GFP reporter expression in neuroblasts.To measure GFP intensities in medulla neuroblasts unimpeded by GFP fluorescence from glial cells, UAS-GFP-RNAi; d5778 850 bp >GFP wild type reporter or UAS-GFP-RNAi; d5778 850 Su(H) binding si... |
PMC9427115_fig9_389252.jpg | What object or scene is depicted here? | Mutation of potential Su(H) binding sites in the d5778 850 bp enhancer does not decrease GFP reporter expression in neuroblasts.To measure GFP intensities in medulla neuroblasts unimpeded by GFP fluorescence from glial cells, UAS-GFP-RNAi; d5778 850 bp >GFP wild type reporter or UAS-GFP-RNAi; d5778 850 Su(H) binding si... |
PMC9427115_fig9_389246.jpg | Can you identify the primary element in this image? | Mutation of potential Su(H) binding sites in the d5778 850 bp enhancer does not decrease GFP reporter expression in neuroblasts.To measure GFP intensities in medulla neuroblasts unimpeded by GFP fluorescence from glial cells, UAS-GFP-RNAi; d5778 850 bp >GFP wild type reporter or UAS-GFP-RNAi; d5778 850 Su(H) binding si... |
PMC9427159_Fig2_389276.jpg | What can you see in this picture? | Bilateral patchy ground-glass opacity areas that were not distinguishable from the residual lesion of COVID-19 were observed on chest computed tomography |
PMC9427171_Fig1_389281.jpg | What can you see in this picture? | Radiological images. A An axial CT brain revealing a right hypodense CPA tumor (asterisk) that enhances following B contrast sequences, with C IAC enlargement. T2-weighted MR image demonstrating heterogeneous intensity lesions on D axial and E coronal sequence. F, G On the T1-weighted post gadolinium, a heterogenous en... |
PMC9427171_Fig1_389285.jpg | What is the focal point of this photograph? | Radiological images. A An axial CT brain revealing a right hypodense CPA tumor (asterisk) that enhances following B contrast sequences, with C IAC enlargement. T2-weighted MR image demonstrating heterogeneous intensity lesions on D axial and E coronal sequence. F, G On the T1-weighted post gadolinium, a heterogenous en... |
PMC9427171_Fig1_389284.jpg | What is the dominant medical problem in this image? | Radiological images. A An axial CT brain revealing a right hypodense CPA tumor (asterisk) that enhances following B contrast sequences, with C IAC enlargement. T2-weighted MR image demonstrating heterogeneous intensity lesions on D axial and E coronal sequence. F, G On the T1-weighted post gadolinium, a heterogenous en... |
PMC9427171_Fig1_389282.jpg | What can you see in this picture? | Radiological images. A An axial CT brain revealing a right hypodense CPA tumor (asterisk) that enhances following B contrast sequences, with C IAC enlargement. T2-weighted MR image demonstrating heterogeneous intensity lesions on D axial and E coronal sequence. F, G On the T1-weighted post gadolinium, a heterogenous en... |
PMC9427171_Fig1_389288.jpg | What is the dominant medical problem in this image? | Radiological images. A An axial CT brain revealing a right hypodense CPA tumor (asterisk) that enhances following B contrast sequences, with C IAC enlargement. T2-weighted MR image demonstrating heterogeneous intensity lesions on D axial and E coronal sequence. F, G On the T1-weighted post gadolinium, a heterogenous en... |
PMC9427171_Fig1_389283.jpg | Describe the main subject of this image. | Radiological images. A An axial CT brain revealing a right hypodense CPA tumor (asterisk) that enhances following B contrast sequences, with C IAC enlargement. T2-weighted MR image demonstrating heterogeneous intensity lesions on D axial and E coronal sequence. F, G On the T1-weighted post gadolinium, a heterogenous en... |
PMC9427171_Fig1_389286.jpg | Describe the main subject of this image. | Radiological images. A An axial CT brain revealing a right hypodense CPA tumor (asterisk) that enhances following B contrast sequences, with C IAC enlargement. T2-weighted MR image demonstrating heterogeneous intensity lesions on D axial and E coronal sequence. F, G On the T1-weighted post gadolinium, a heterogenous en... |
PMC9427171_Fig2_389280.jpg | What's the most prominent thing you notice in this picture? | Hematoxylin–eosin stain. The tumor shows a biphasic appearance with A compact fibrillar area, and B loose microcystic area (× 10 magnification). C Rosenthal fibers (orange arrow) and eosinophilic granular bodies (red arrow) are present (× 20 magnification). D Immunohistochemical expression of positive glial fibrillary ... |
PMC9427171_Fig2_389278.jpg | What is the core subject represented in this visual? | Hematoxylin–eosin stain. The tumor shows a biphasic appearance with A compact fibrillar area, and B loose microcystic area (× 10 magnification). C Rosenthal fibers (orange arrow) and eosinophilic granular bodies (red arrow) are present (× 20 magnification). D Immunohistochemical expression of positive glial fibrillary ... |
PMC9427171_Fig2_389277.jpg | What object or scene is depicted here? | Hematoxylin–eosin stain. The tumor shows a biphasic appearance with A compact fibrillar area, and B loose microcystic area (× 10 magnification). C Rosenthal fibers (orange arrow) and eosinophilic granular bodies (red arrow) are present (× 20 magnification). D Immunohistochemical expression of positive glial fibrillary ... |
PMC9427180_f2_389289.jpg | What is the core subject represented in this visual? | Abdominal tomography without pneumoperitoneum and with thickening of the concentric intestinal wall, without signs of intestinal perforation. |
PMC9427202_f1_389290.jpg | What stands out most in this visual? | Endoscopy image that reveals the presence of the GIST in subcardial position. |
PMC9427202_f2_389292.jpg | What is the principal component of this image? | PET-CT image who shows the localisation of the GIST. |
PMC9427202_f2_389293.jpg | Describe the main subject of this image. | PET-CT image who shows the localisation of the GIST. |
PMC9427231_fig2_389298.jpg | Describe the main subject of this image. | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427231_fig2_389303.jpg | What's the most prominent thing you notice in this picture? | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427231_fig2_389304.jpg | What is the principal component of this image? | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427231_fig2_389305.jpg | What stands out most in this visual? | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427231_fig2_389302.jpg | Can you identify the primary element in this image? | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427231_fig2_389296.jpg | What is the central feature of this picture? | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427231_fig2_389299.jpg | What stands out most in this visual? | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427231_fig2_389294.jpg | What does this image primarily show? | 3D brain tumor MRI images of the REMBRANDT dataset. |
PMC9427255_fig2_389306.jpg | Describe the main subject of this image. | Application of Cameriere's method for dental age estimation according to a panoramic radiograph. |
PMC9427257_fig4_389307.jpg | What is the core subject represented in this visual? | Assessment of myocardial infarction using TTC staining technique in different groups of animals. ISP: Isoproterenol; CFME-LD: CFME at lower dose (250 mg/kg); CFME-HD: CFME at higher dose (500 mg/kg). |
PMC9427257_fig5_389313.jpg | What is the dominant medical problem in this image? | Histopathological observation (magnification at ×100) of ISP-induced myocardial infarction in different groups of the animal model. ISP: Isoproterenol; CFME-LD: CFME at lower dose (250 mg/kg); CFME-HD: CFME at higher dose (500 mg/kg). The arrow mark represents inflammatory accumulation. |
PMC9427257_fig5_389310.jpg | What's the most prominent thing you notice in this picture? | Histopathological observation (magnification at ×100) of ISP-induced myocardial infarction in different groups of the animal model. ISP: Isoproterenol; CFME-LD: CFME at lower dose (250 mg/kg); CFME-HD: CFME at higher dose (500 mg/kg). The arrow mark represents inflammatory accumulation. |
PMC9427257_fig5_389312.jpg | What can you see in this picture? | Histopathological observation (magnification at ×100) of ISP-induced myocardial infarction in different groups of the animal model. ISP: Isoproterenol; CFME-LD: CFME at lower dose (250 mg/kg); CFME-HD: CFME at higher dose (500 mg/kg). The arrow mark represents inflammatory accumulation. |
PMC9427257_fig5_389309.jpg | What is the focal point of this photograph? | Histopathological observation (magnification at ×100) of ISP-induced myocardial infarction in different groups of the animal model. ISP: Isoproterenol; CFME-LD: CFME at lower dose (250 mg/kg); CFME-HD: CFME at higher dose (500 mg/kg). The arrow mark represents inflammatory accumulation. |
PMC9427298_fig1_389316.jpg | What is the core subject represented in this visual? | Surgical procedure of ERCP in the treatment of biliary strictures after liver transplantation. (a) Before ERCP, cholangiography showed biliary strictures; (b) the Boston zebra guide wire was placed into the intrahepatic bile duct; (c) the plastic stent was successfully placed with balloon dilator; (d) metal stent place... |
PMC9427298_fig1_389315.jpg | What object or scene is depicted here? | Surgical procedure of ERCP in the treatment of biliary strictures after liver transplantation. (a) Before ERCP, cholangiography showed biliary strictures; (b) the Boston zebra guide wire was placed into the intrahepatic bile duct; (c) the plastic stent was successfully placed with balloon dilator; (d) metal stent place... |
PMC9427298_fig1_389317.jpg | Describe the main subject of this image. | Surgical procedure of ERCP in the treatment of biliary strictures after liver transplantation. (a) Before ERCP, cholangiography showed biliary strictures; (b) the Boston zebra guide wire was placed into the intrahepatic bile duct; (c) the plastic stent was successfully placed with balloon dilator; (d) metal stent place... |
PMC9427300_fig3_389319.jpg | What key item or scene is captured in this photo? | Chest radiograph showing a prominent upper right mediastinum (arrow) as the correlation of the azygos continuation entering the vena cava superior in a cross-sectional view. |
PMC9427306_fig1_389320.jpg | What is being portrayed in this visual content? | Chest computed tomography scans showing changes in the lung lesions. (a) CT scan performed on Day 17. (b) CT scan performed on Day 21. The second CT scan shows a clear improvement compared to the CT scan performed 4 days earlier. CT: computed tomography. |
PMC9427306_fig1_389321.jpg | What can you see in this picture? | Chest computed tomography scans showing changes in the lung lesions. (a) CT scan performed on Day 17. (b) CT scan performed on Day 21. The second CT scan shows a clear improvement compared to the CT scan performed 4 days earlier. CT: computed tomography. |
PMC9427307_fig1_389324.jpg | What object or scene is depicted here? | Preoperative findings and histopathological analysis of the resected specimen. Upper endoscopy revealing a semicircular type 2 tumor on the greater curvature of the gastric corpus that extends to the pylorus (a). Contrast-enhanced computed tomography depicting bulky thickening of the distal stomach wall, without invasi... |
PMC9427307_fig1_389331.jpg | What does this image primarily show? | Preoperative findings and histopathological analysis of the resected specimen. Upper endoscopy revealing a semicircular type 2 tumor on the greater curvature of the gastric corpus that extends to the pylorus (a). Contrast-enhanced computed tomography depicting bulky thickening of the distal stomach wall, without invasi... |
PMC9427307_fig1_389330.jpg | What can you see in this picture? | Preoperative findings and histopathological analysis of the resected specimen. Upper endoscopy revealing a semicircular type 2 tumor on the greater curvature of the gastric corpus that extends to the pylorus (a). Contrast-enhanced computed tomography depicting bulky thickening of the distal stomach wall, without invasi... |
PMC9427307_fig1_389328.jpg | What does this image primarily show? | Preoperative findings and histopathological analysis of the resected specimen. Upper endoscopy revealing a semicircular type 2 tumor on the greater curvature of the gastric corpus that extends to the pylorus (a). Contrast-enhanced computed tomography depicting bulky thickening of the distal stomach wall, without invasi... |
PMC9427307_fig1_389326.jpg | What is the principal component of this image? | Preoperative findings and histopathological analysis of the resected specimen. Upper endoscopy revealing a semicircular type 2 tumor on the greater curvature of the gastric corpus that extends to the pylorus (a). Contrast-enhanced computed tomography depicting bulky thickening of the distal stomach wall, without invasi... |
PMC9427307_fig3_389333.jpg | What does this image primarily show? | Radiological findings following liver metastasis (segment 5/6) from AFP-producing gastric carcinoma contrast-enhanced computed tomography revealing a hypovascular nodule in segment 5/6 of the liver (a, b). T1- and T2-weighted MRI showing a low-signal nodule and slightly high signal, respectively; a 9 mm defect is obser... |
PMC9427307_fig3_389337.jpg | What can you see in this picture? | Radiological findings following liver metastasis (segment 5/6) from AFP-producing gastric carcinoma contrast-enhanced computed tomography revealing a hypovascular nodule in segment 5/6 of the liver (a, b). T1- and T2-weighted MRI showing a low-signal nodule and slightly high signal, respectively; a 9 mm defect is obser... |
PMC9427307_fig3_389334.jpg | What is the principal component of this image? | Radiological findings following liver metastasis (segment 5/6) from AFP-producing gastric carcinoma contrast-enhanced computed tomography revealing a hypovascular nodule in segment 5/6 of the liver (a, b). T1- and T2-weighted MRI showing a low-signal nodule and slightly high signal, respectively; a 9 mm defect is obser... |
PMC9427307_fig3_389336.jpg | What does this image primarily show? | Radiological findings following liver metastasis (segment 5/6) from AFP-producing gastric carcinoma contrast-enhanced computed tomography revealing a hypovascular nodule in segment 5/6 of the liver (a, b). T1- and T2-weighted MRI showing a low-signal nodule and slightly high signal, respectively; a 9 mm defect is obser... |
PMC9427307_fig3_389338.jpg | What's the most prominent thing you notice in this picture? | Radiological findings following liver metastasis (segment 5/6) from AFP-producing gastric carcinoma contrast-enhanced computed tomography revealing a hypovascular nodule in segment 5/6 of the liver (a, b). T1- and T2-weighted MRI showing a low-signal nodule and slightly high signal, respectively; a 9 mm defect is obser... |
PMC9427307_fig3_389332.jpg | What is the dominant medical problem in this image? | Radiological findings following liver metastasis (segment 5/6) from AFP-producing gastric carcinoma contrast-enhanced computed tomography revealing a hypovascular nodule in segment 5/6 of the liver (a, b). T1- and T2-weighted MRI showing a low-signal nodule and slightly high signal, respectively; a 9 mm defect is obser... |
PMC9427312_fig1_389340.jpg | What's the most prominent thing you notice in this picture? | Computed tomography angiography (CTA) showed pulmonary embolism (yellow arrow) in the first patient (a, b). |
PMC9427312_fig2_389344.jpg | What is being portrayed in this visual content? | Angiographic imaging of Angiojet system in the first patient. |
PMC9427312_fig2_389345.jpg | What's the most prominent thing you notice in this picture? | Angiographic imaging of Angiojet system in the first patient. |
PMC9427312_fig3_389346.jpg | What stands out most in this visual? | Computed tomography angiography (CTA) showed pulmonary embolism (yellow arrow) in the second patient (a, b). |
PMC9427312_fig3_389347.jpg | What is the core subject represented in this visual? | Computed tomography angiography (CTA) showed pulmonary embolism (yellow arrow) in the second patient (a, b). |
PMC9427312_fig4_389343.jpg | What is the main focus of this visual representation? | Angiographic imaging of Angiojet system in the second patient. |
PMC9427312_fig4_389342.jpg | What is the core subject represented in this visual? | Angiographic imaging of Angiojet system in the second patient. |
PMC9427312_fig6_389348.jpg | What is the core subject represented in this visual? | Computed tomography angiography (CTA) showed pulmonary embolism disappearance in the second patient. |
PMC9427313_fig1_389356.jpg | What does this image primarily show? | POCUS and CTA of case 1. (a) POCUS shows portal vein at hepatic hilum (asterisk) with multiple hyperechogenic spots into the lumen. White arrows indicate air in intrahepatic portal vessels with altered liver ultrasonographic structure. (b) A CTA scan confirms air into the liver (white arrows), while air is not easily i... |
PMC9427313_fig2_389353.jpg | What's the most prominent thing you notice in this picture? | POCUS and CTA of case 2. (a) POCUS shows a right portal branch (asterisk) with some air bubbles into the lumen (black arrow). White arrows indicate some air in intrahepatic portal vessels. (b) CTA showing pneumatosis intestinalis (white arrow). (c) CTA shows the air flowing within the intestinal vessels (white arrow), ... |
PMC9427313_fig2_389352.jpg | What's the most prominent thing you notice in this picture? | POCUS and CTA of case 2. (a) POCUS shows a right portal branch (asterisk) with some air bubbles into the lumen (black arrow). White arrows indicate some air in intrahepatic portal vessels. (b) CTA showing pneumatosis intestinalis (white arrow). (c) CTA shows the air flowing within the intestinal vessels (white arrow), ... |
PMC9427314_fig2_389350.jpg | What's the most prominent thing you notice in this picture? | Conventional MRI image. Note: (a, b) conventional MRI images, showing poorly defined boundaries of the pancreas. |
PMC9427314_fig2_389349.jpg | Can you identify the primary element in this image? | Conventional MRI image. Note: (a, b) conventional MRI images, showing poorly defined boundaries of the pancreas. |
PMC9427439_Fig1_389361.jpg | What key item or scene is captured in this photo? | a Eu-doped iron oxide particles and a Gd-based contrast agent were analysed by LA-ICP-MS in control, early, and advanced atherosclerotic plaque progression. Scale bars, 500 µm, ROI, 200 µm. b Comparison of Fe concentrations and Eu signal intensity in atherosclerotic plaques. Reprinted from Springer Nature, Molecular Im... |
PMC9427439_Fig1_389366.jpg | What is shown in this image? | a Eu-doped iron oxide particles and a Gd-based contrast agent were analysed by LA-ICP-MS in control, early, and advanced atherosclerotic plaque progression. Scale bars, 500 µm, ROI, 200 µm. b Comparison of Fe concentrations and Eu signal intensity in atherosclerotic plaques. Reprinted from Springer Nature, Molecular Im... |
PMC9427439_Fig1_389358.jpg | What can you see in this picture? | a Eu-doped iron oxide particles and a Gd-based contrast agent were analysed by LA-ICP-MS in control, early, and advanced atherosclerotic plaque progression. Scale bars, 500 µm, ROI, 200 µm. b Comparison of Fe concentrations and Eu signal intensity in atherosclerotic plaques. Reprinted from Springer Nature, Molecular Im... |
PMC9427439_Fig1_389362.jpg | What key item or scene is captured in this photo? | a Eu-doped iron oxide particles and a Gd-based contrast agent were analysed by LA-ICP-MS in control, early, and advanced atherosclerotic plaque progression. Scale bars, 500 µm, ROI, 200 µm. b Comparison of Fe concentrations and Eu signal intensity in atherosclerotic plaques. Reprinted from Springer Nature, Molecular Im... |
PMC9427439_Fig1_389364.jpg | What is the core subject represented in this visual? | a Eu-doped iron oxide particles and a Gd-based contrast agent were analysed by LA-ICP-MS in control, early, and advanced atherosclerotic plaque progression. Scale bars, 500 µm, ROI, 200 µm. b Comparison of Fe concentrations and Eu signal intensity in atherosclerotic plaques. Reprinted from Springer Nature, Molecular Im... |
PMC9427735_Fig3_389380.jpg | What is shown in this image? | Localization of the ingested fluorescently labelled dsRNAs-TuCOPB2-100 and dsRNAs-TuCOPB2-400 following 24 h of mite feeding. (A) Fluorescence of labeled dsRNAs is seen in the mite caeca lumen (c) and digestive cells (dc); free fluorescein-12-UTP localizes in the posterior midgut (pm); guanine pellets (g), located in t... |
PMC9427735_Fig3_389368.jpg | What is the focal point of this photograph? | Localization of the ingested fluorescently labelled dsRNAs-TuCOPB2-100 and dsRNAs-TuCOPB2-400 following 24 h of mite feeding. (A) Fluorescence of labeled dsRNAs is seen in the mite caeca lumen (c) and digestive cells (dc); free fluorescein-12-UTP localizes in the posterior midgut (pm); guanine pellets (g), located in t... |
PMC9427735_Fig3_389371.jpg | What is the core subject represented in this visual? | Localization of the ingested fluorescently labelled dsRNAs-TuCOPB2-100 and dsRNAs-TuCOPB2-400 following 24 h of mite feeding. (A) Fluorescence of labeled dsRNAs is seen in the mite caeca lumen (c) and digestive cells (dc); free fluorescein-12-UTP localizes in the posterior midgut (pm); guanine pellets (g), located in t... |
PMC9427735_Fig3_389379.jpg | What can you see in this picture? | Localization of the ingested fluorescently labelled dsRNAs-TuCOPB2-100 and dsRNAs-TuCOPB2-400 following 24 h of mite feeding. (A) Fluorescence of labeled dsRNAs is seen in the mite caeca lumen (c) and digestive cells (dc); free fluorescein-12-UTP localizes in the posterior midgut (pm); guanine pellets (g), located in t... |
PMC9427735_Fig3_389369.jpg | What is the core subject represented in this visual? | Localization of the ingested fluorescently labelled dsRNAs-TuCOPB2-100 and dsRNAs-TuCOPB2-400 following 24 h of mite feeding. (A) Fluorescence of labeled dsRNAs is seen in the mite caeca lumen (c) and digestive cells (dc); free fluorescein-12-UTP localizes in the posterior midgut (pm); guanine pellets (g), located in t... |
PMC9427735_Fig3_389370.jpg | What key item or scene is captured in this photo? | Localization of the ingested fluorescently labelled dsRNAs-TuCOPB2-100 and dsRNAs-TuCOPB2-400 following 24 h of mite feeding. (A) Fluorescence of labeled dsRNAs is seen in the mite caeca lumen (c) and digestive cells (dc); free fluorescein-12-UTP localizes in the posterior midgut (pm); guanine pellets (g), located in t... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.